Cellular Biomedicine Group, Inc. 5
5 · Cellular Biomedicine Group, Inc. · Filed Jun 6, 2013
Insider Transaction Report
Form 5
Klein Norman Paul II
DirectorCorporate Operating Officer
Transactions
- Sale
Common Stock
2011-05-16$0.10/sh−10,000$1,000→ 13,725,540 total - Sale
Common Stock
2011-06-06$0.06/sh−1,000$60→ 13,661,190 total - Sale
Common Stock
2011-06-28$0.06/sh−5,500$330→ 13,570,324 total - Sale
Common Stock
2011-06-30$0.06/sh−8,134$488→ 13,562,190 total - Sale
Common Stock
2011-05-09$0.10/sh−25,000$2,550→ 13,737,190 total - Sale
Common Stock
2011-05-25$0.10/sh−25,000$2,375→ 13,687,190 total - Sale
Common Stock
2011-06-07$0.06/sh−24,000$1,440→ 13,637,190 total - Sale
Common Stock
2011-06-17$0.07/sh−25,000$1,625→ 13,587,190 total - Sale
Common Stock
2011-07-07$0.06/sh−800$48→ 13,561,390 total - Sale
Common Stock
2011-04-21$0.10/sh−25,000$2,375→ 13,812,190 total - Sale
Common Stock
2011-05-03$0.09/sh−25,000$2,250→ 13,762,190 total - Sale
Common Stock
2011-05-26$0.09/sh−1,000$90→ 13,686,190 total - Sale
Common Stock
2011-04-20$0.11/sh−50,000$5,300→ 13,837,190 total - Sale
Common Stock
2011-06-08$0.07/sh−25,000$1,625→ 13,612,190 total - Sale
Common Stock
2011-02-11$0.10/sh−54,995$5,500→ 13,887,190 total - Sale
Common Stock
2011-04-26$0.09/sh−1,000$93→ 13,811,190 total - Sale
Common Stock
2011-04-28$0.09/sh−24,000$2,232→ 13,787,190 total - Sale
Common Stock
2011-05-13$0.10/sh−1,650$165→ 13,735,540 total - Sale
Common Stock
2011-05-19$0.10/sh−13,350$1,335→ 13,712,190 total - Sale
Common Stock
2011-06-02$0.07/sh−24,000$1,560→ 13,662,190 total - Sale
Common Stock
2011-06-22$0.06/sh−11,366$682→ 13,575,824 total
Footnotes (1)
- [F1]Error in the number of Beneficial shares reports on Form 4 filed on 2/11/11.